Genetic polymorphisms are implicated in the pathophysiology of NASH, prompting an investigation into IL-6 and IL-8 gene polymorphisms in NASH pathogenesis. The gene discussed is IL6; the disease is metabolic dysfunction-associated steatohepatitis.